Literature DB >> 2928652

Nonmenstrual toxic shock syndrome associated with barrier contraceptives: report of a case-control study.

B Schwartz1, S Gaventa, C V Broome, A L Reingold, A W Hightower, J A Perlman, P H Wolf.   

Abstract

Use of barrier contraceptives has been hypothesized to be a risk factor for nonmenstrual toxic shock syndrome (TSS). This association was evaluated in a case-control study of nonmenstrual TSS; cases were identified through an active surveillance system for TSS during 1986 and 1987. Potential risk factors for nonmenstrual TSS were compared for 28 patients and 100 age-matched controls. Use of barrier contraceptives was associated with a significantly increased risk of nonmenstrual TSS, with matched odds ratios of 10.5 and 11.7 for contraceptive sponge and diaphragm use, respectively. Use of nonbarrier contraceptive methods was unrelated to nonmenstrual TSS. Despite the elevated odds ratio, the incidence of nonmenstrual TSS in barrier contraceptives users and the risk of nonmenstrual TSS attributable to barrier contraceptive use are low. Clinicians and women who use barrier contraceptives should be aware of this rare but potentially fatal complication; however, other considerations, such as efficacy and complications associated with other types of contraception, may be more important in the choice of a contraceptive method.

Entities:  

Keywords:  Americas; Barrier Methods; Case Studies; Contraception; Contraceptive Methods; Contraceptive Usage; Control Groups; Data Analysis; Data Collection; Developed Countries; Diseases; Family Planning; Incidence; Infections; Measurement; North America; Northern America; Research Methodology; Studies; Toxic Shock Syndrome--etiology; United States

Mesh:

Year:  1989        PMID: 2928652     DOI: 10.1093/clinids/11.supplement_1.s43

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  4 in total

1.  Vaginal Staphylococcus aureus superantigen profile shift from 1980 and 1981 to 2003, 2004, and 2005.

Authors:  Patrick M Schlievert; Laura C Case; Kristi L Strandberg; Timothy J Tripp; Ying-Chi Lin; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

2.  A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses.

Authors:  M K Howett; E B Neely; N D Christensen; B Wigdahl; F C Krebs; D Malamud; S D Patrick; M D Pickel; P A Welsh; C A Reed; M G Ward; L R Budgeon; J W Kreider
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

3.  Examining the safety of menstrual cups among rural primary school girls in western Kenya: observational studies nested in a randomised controlled feasibility study.

Authors:  Jane Juma; Elizabeth Nyothach; Kayla F Laserson; Clifford Oduor; Lilian Arita; Caroline Ouma; Kelvin Oruko; Jackton Omoto; Linda Mason; Kelly T Alexander; Barry Fields; Clayton Onyango; Penelope A Phillips-Howard
Journal:  BMJ Open       Date:  2017-05-04       Impact factor: 2.692

4.  Menstrual cup use, leakage, acceptability, safety, and availability: a systematic review and meta-analysis.

Authors:  Anna Maria van Eijk; Garazi Zulaika; Madeline Lenchner; Linda Mason; Muthusamy Sivakami; Elizabeth Nyothach; Holger Unger; Kayla Laserson; Penelope A Phillips-Howard
Journal:  Lancet Public Health       Date:  2019-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.